AK130

DRUG4 trials

Sponsors

Akeso

Conditions

Advanced Malignant TumorsBiliary Tract CancerHepatocellular CarcinomaPancreatic Cancer

Phase 1

A Study of AK130 in Patients With Advanced Malignant Tumors

CompletedNCT05653284

AkesoAdvanced Malignant Tumors

Start: 2023-02-09End: 2024-05-30Updated: 2024-08-13

A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)

RecruitingNCT06530251

AkesoHepatocellular Carcinoma

Start: 2024-09-24End: 2028-09-01Target: 280Updated: 2026-03-04

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

RecruitingNCT06938321

AkesoBiliary Tract Cancer

Start: 2025-04-30End: 2027-12-01Target: 135Updated: 2026-03-03

Phase 2

A Study of AK130 in Combination With AK112 for the Treatment of Advanced Pancreatic Cancer

RecruitingNCT07114315

AkesoPancreatic Cancer

Start: 2025-09-19End: 2028-08-01Target: 160Updated: 2026-03-03